background image

Geopolitics A Ticking Bomb?

Summary:  Asia equities broadly higher and sweeping aside the mounting tensions between the US and China, instead focusing on the perceived positives which have driven risk assets in recent weeks. Namely reopening economies, slowing COVID-19 case growth and expanding central bank balance sheets.


We still maintain, the failure of the S&P 500 to sustain above the bear market retracement zone, bears watching into tomorrow’s cash session (US markets closed for Memorial Day tonight) particularly as sentiment continues to flip flop and upside momentum looks to be stalling. However, as we have previously noted, risk assets are not being driven by pervasive uncertainties and reopening realities. The hope trade is firmly rooted in abundant liquidity and the promise of more if necessary, along with the speculative flows of retail traders driven up the risk spectrum via the lack of alternative (TINA) and the expectation that rates will remain low for an extended period. The rise of zero commission trading and ease of online account opening has fuelled the retail flows, which in the long run may serve to democratise financial markets. However, there is also the continued expectations that central banks will fix all ills and are equipped to backstop asset prices against a fundamental backdrop that has arguably never been so uncertain. The sharp rebound of March lows in turn drives continued speculative behaviour, as the fear of missing out (FOMO) becomes a driver and in this paradigm markets remain biased to the upside.

Fundamentally, it seems markets have run ahead of reality in pricing the recovery, particularly given a wide range of consumer, economic, and pandemic (vaccine/2nd wave) probabilities exist. For that reason, we remain on high alert for the “trading on hope” narrative reversing and remain cautious on the short-term risk reward across equities at present levels.

Are rising US/China trade tensions enough to snap the positive bias? Markets have typically traded on the hope that the rhetoric is worse than reality when it comes to the US/China disentanglement. Now it seems that each day brings fresh evidence that the relationship has permanently changed and the global geopolitical architectures, which have long been fraying, are moving closer to breaking point. The ideological differences and political fragmentations that drove the original US/SINO confrontations are on full display and the tectonic shifts like, the East/West divide, Splinternet, and supply chain relocations we talked about when trade tensions first emerged are now coming to fruition. Beijing revealed plans on Friday to impose laws on Hong Kong that would ban subversion, secession, foreign interference and any acts that threaten national security. With China’s strike on Hong Kong comes the ultimate test of whether this US administration’s hawkish position on China “bark” is worse than the “bite”. Particularly as the tough stance on china plays into the election strategy and diverts attention from the handling of the health crisis, whilst shifting blame to China.

The rebuttal from the US will be closely watched, to date White House economic adviser Kevin Hassett has stated that the US government is “absolutely not going to give China a pass” and is threatening punitive actions. Revoking Hong Kong’s special trading status, along with sanctioning individuals and entities involved in enforcing the proposed new security law in Hong Kong have been floated, but talk is cheap and we await the US response.

Although the CNY fix today was stronger than estimated, illustrating the PBOC acted to slow the CNY decline, the fix was the weakest since 2008. USDCNY bears watching closely as a barometer of China’s intent and proxy for the state of US/Sino relations, the PBOC has previously made it very clear the Yuan is not a one-way bet and do not want a disorderly panicked move. However, the slow and steady depreciation is in play. The yuan will weaken to offset renewed tariff risk but also remains under fundamental market pressures. As the $CNY exchange rate approaches 7.20, no doubt angst will be on the rise but the manner of the depreciation will determine the resultant risk asset response. The more disorderly, the greater the fallout.

25_ELEC_01
Source: Bloomberg

As the US and China go head to head in the battle for hegemony, Australia is caught in the middle of the two superpowers. With the mounting US/China tensions comes an increasingly difficult trajectory for Australia to navigate.

Global times, Australia should distance itself from a possible new China-US ‘cold war’

Mike Pompeo warns US could 'disconnect' from Australia over Victoria's Belt and Road deal

Balancing the ideological and national security allegiance with the US and the trade relationship with China leaves Australia in a difficult position. Although the Australian government have asserted that Australia is not under pressure to pick sides. Recent actions and commentary from both China and the US appears to the contrary. China’s dominant purchasing position for Australian goods potentially comes with a price Australia is not willing to pay, as recent support of the independent investigation into the origins of COVID-19 have prompted retaliatory reactions from China motivated by economic coercion and resulted in tariffs on Barley imports to China and the banning of some beef imports. By this token, the pandemic outbreak could prove a pivotal moment for the long run relationship between China and Australia. Whilst the present industry attacks are no doubt harmful at the individual level, in terms of the broad GDP impact they are minimal. However, China accounts for more than 30% of goods and services exports and a more serious reduction in Chinese demand like a consumer boycott of Australian goods and services exports (education/tourism), targeting iron ore, or coal exports would pose a far greater and more damaging impact.

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.